PLAINSBORO, N.J., Aug. 27, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that, effective today, Mr. Neal Moszkowski has retired from the Board of Directors. The Board has appointed Donald Morel as a Director of the Company.
"Neal's service to Integra over the past seven years, and for a total of thirteen years, has been extremely valuable," said Stuart Essig, Chairman of Integra's Board of Directors. "We are thankful for his contributions to the Company during his tenure on the Board and its Nominating and Corporate Governance and Compensation Committees."
Peter Arduini, Integra's President, Chief Executive Officer and Director stated, "Dr. Morel is a healthcare executive with extensive management and product development experience. He has a particular interest and expertise in biomaterials. His tenure at West Pharmaceutical and broad experience in our industry will add a valuable perspective on Integra. I am delighted that Dr. Morel has agreed to join our Board of Directors."Dr. Morel is currently the Chief Executive Officer and Chairman of the Board of Directors of West Pharmaceutical Services, Inc., a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. Dr. Morel has served as the Chief Executive Officer and a Director of West Pharmaceutical Services, Inc. since 2002 and as Chairman of the Board of Directors since 2003. Dr. Morel served as a Director of Kensey Nash Corporation, a medical device product development and manufacturing company, from March 2010 to June 2012 as well as a member of its audit and compensation committees. He serves as Chairman of the Board of Directors of the American Oncologic Hospital of the Fox Chase Cancer Center and as a member of the board of trustees of The Franklin Institute and of Lafayette College. Dr. Morel received a B.S. in Engineering from Lafayette College and an M.S. and Ph.D. in Materials Science from Cornell University.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV